908 Devices Inc
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of… Read more
908 Devices Inc (MASS) - Total Assets
Latest total assets as of December 2025: $190.07 Million USD
Based on the latest financial reports, 908 Devices Inc (MASS) holds total assets worth $190.07 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
908 Devices Inc - Total Assets Trend (2018–2025)
This chart illustrates how 908 Devices Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
908 Devices Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
908 Devices Inc's total assets of $190.07 Million consist of 76.1% current assets and 23.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 59.4% |
| Accounts Receivable | $11.33 Million | 6.0% |
| Inventory | $12.99 Million | 6.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $36.41 Million | 19.2% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how 908 Devices Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: 908 Devices Inc's current assets represent 76.1% of total assets in 2025, an increase from 62.0% in 2018.
- Cash Position: Cash and equivalents constituted 59.4% of total assets in 2025, up from 25.5% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 19.2% of total assets.
908 Devices Inc Competitors by Total Assets
Key competitors of 908 Devices Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
908 Devices Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - 908 Devices Inc generates 0.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, 908 Devices Inc generates $ 10.25 in net profit.
908 Devices Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.24 | 4.10 | 17.62 |
| Quick Ratio | 3.86 | 3.45 | 16.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $110.50 Million | $ 77.91 Million | $ 153.71 Million |
908 Devices Inc - Advanced Valuation Insights
This section examines the relationship between 908 Devices Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.60 |
| Latest Market Cap to Assets Ratio | 0.71 |
| Asset Growth Rate (YoY) | 19.2% |
| Total Assets | $190.07 Million |
| Market Capitalization | $135.59 Million USD |
Valuation Analysis
Below Book Valuation: The market values 908 Devices Inc's assets below their book value (0.71 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: 908 Devices Inc's assets grew by 19.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for 908 Devices Inc (2018–2025)
The table below shows the annual total assets of 908 Devices Inc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $190.07 Million | +19.18% |
| 2024-12-31 | $159.48 Million | -21.43% |
| 2023-12-31 | $202.98 Million | -16.33% |
| 2022-12-31 | $242.59 Million | -7.02% |
| 2021-12-31 | $260.91 Million | +45.90% |
| 2020-12-31 | $178.83 Million | +374.82% |
| 2019-12-31 | $37.66 Million | +35.73% |
| 2018-12-31 | $27.75 Million | -- |